Kazuki Terashima
Overview
Explore the profile of Kazuki Terashima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
625
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Komatsu S, Nagamata S, Terashima K, Demizu Y, Suga M, Kido M, et al.
Ann Surg Oncol
. 2025 Feb;
PMID: 40000562
Background: The effectiveness of local treatment in lymph node metastasis from uterine cancer has been proven; the standard treatment is surgical intervention. Although radiotherapy, including particle radiotherapy (PRT), is an...
2.
Komatsu S, Yano Y, Terashima K, Fujishima Y, Ishida J, Ishihara N, et al.
Surg Today
. 2025 Feb;
PMID: 39934306
Purpose: The prognosis of patients with hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) in the first-order or main trunk/contralateral branches (Vp3/4) is poor. The present study aimed to...
3.
Chhabra A, Amos R, Simone 2nd C, Simone C, Kaiser A, Perles L, et al.
Int J Radiat Oncol Biol Phys
. 2025 Jan;
PMID: 39761799
Radiation therapy manages pancreatic cancer in various settings; however, the proximity of gastrointestinal (GI) luminal organs at risk (OARs) poses challenges to conventional radiation therapy. Proton beam therapy (PBT) may...
4.
Kusuhara T, Gon H, Terashima K, Komatsu S, Matsuo Y, Tokumaru S, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):1116.
PMID: 39542960
No abstract available.
5.
Kusuhara T, Gon H, Terashima K, Komatsu S, Matsuo Y, Tokumaru S, et al.
Ann Surg Oncol
. 2024 Oct;
32(1):448-449.
PMID: 39460816
No abstract available.
6.
Kusuhara T, Gon H, Terashima K, Komatsu S, Matsuo Y, Tokumaru S, et al.
Ann Surg Oncol
. 2024 Oct;
32(2):1073-1082.
PMID: 39453585
Background: Particle therapy (PT) as an initial hepatocellular carcinoma (HCC) treatment has been reported to be effective; however, its efficacy for the treatment of recurrent HCC remains unclear. Objective: This...
7.
Kubota H, Demizu Y, Iwashita K, Fukumitsu N, Takahashi D, Park S, et al.
Clin Transl Radiat Oncol
. 2024 Oct;
49:100864.
PMID: 39398357
Background: Particle therapy is effective for the treatment of soft tissue sarcomas. However, the clinical outcomes of definitive particle therapy, particularly for dedifferentiated liposarcoma (DDLS), remain unknown. Purpose: To analyze...
8.
Mizumoto M, Terashima K, Makishima H, Suzuki M, Ogino T, Waki T, et al.
Liver Cancer
. 2024 May;
13(2):161-168.
PMID: 38751552
Introduction: Intrahepatic cholangiocarcinoma (ICC) can be treated with chemotherapy in unresectable cases, but outcomes are poor. Proton beam therapy (PBT) may provide an alternative treatment and has good dose concentration...
9.
Komatsu S, Terashima K, Ishihara N, Matsuo Y, Kido M, Yanagimoto H, et al.
Surg Today
. 2024 Mar;
54(8):972-976.
PMID: 38436718
Owing to the high objective response rate of atezolizumab plus bevacizumab (Atez/Bev) for hepatocellular carcinoma (HCC), the concept of sequential conversion to local treatment has recently become mainstream. The conversion...
10.
Fujinaka R, Komatsu S, Terashima K, Demizu Y, Omiya S, Kido M, et al.
Radiat Oncol
. 2023 Oct;
18(1):173.
PMID: 37875956
Background: Spacer placement surgery is useful in particle therapy (PT) for patients with abdominopelvic malignant tumors located adjacent to the gastrointestinal tract. This study aimed to assess the safety, efficacy,...